196 related articles for article (PubMed ID: 24728007)
1. Identification of a novel G2073A mutation in 23S rRNA in amphenicol-selected mutants of Campylobacter jejuni.
Ma L; Shen Z; Naren G; Li H; Xia X; Wu C; Shen J; Zhang Q; Wang Y
PLoS One; 2014; 9(4):e94503. PubMed ID: 24728007
[TBL] [Abstract][Full Text] [Related]
2. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.
Gibreel A; Kos VN; Keelan M; Trieber CA; Levesque S; Michaud S; Taylor DE
Antimicrob Agents Chemother; 2005 Jul; 49(7):2753-9. PubMed ID: 15980346
[TBL] [Abstract][Full Text] [Related]
3. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni.
Caldwell DB; Wang Y; Lin J
Antimicrob Agents Chemother; 2008 Nov; 52(11):3947-54. PubMed ID: 18779354
[TBL] [Abstract][Full Text] [Related]
4. 23S rRNA gene mutations contributing to macrolide resistance in Campylobacter jejuni and Campylobacter coli.
Ladely SR; Meinersmann RJ; Englen MD; Fedorka-Cray PJ; Harrison MA
Foodborne Pathog Dis; 2009; 6(1):91-8. PubMed ID: 19014274
[TBL] [Abstract][Full Text] [Related]
5. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni.
Hao H; Dai M; Wang Y; Peng D; Liu Z; Yuan Z
Microb Drug Resist; 2009 Dec; 15(4):239-44. PubMed ID: 19857128
[TBL] [Abstract][Full Text] [Related]
6. Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni.
Hao H; Yuan Z; Shen Z; Han J; Sahin O; Liu P; Zhang Q
Antimicrob Agents Chemother; 2013 Mar; 57(3):1369-78. PubMed ID: 23274667
[TBL] [Abstract][Full Text] [Related]
7. Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli.
Lehtopolku M; Kotilainen P; Haanperä-Heikkinen M; Nakari UM; Hänninen ML; Huovinen P; Siitonen A; Eerola E; Jalava J; Hakanen AJ
Antimicrob Agents Chemother; 2011 Dec; 55(12):5939-41. PubMed ID: 21911571
[TBL] [Abstract][Full Text] [Related]
8. A seventeen-year observation of the antimicrobial susceptibility of clinical Campylobacter jejuni and the molecular mechanisms of erythromycin-resistant isolates in Beijing, China.
Zhou J; Zhang M; Yang W; Fang Y; Wang G; Hou F
Int J Infect Dis; 2016 Jan; 42():28-33. PubMed ID: 26594011
[TBL] [Abstract][Full Text] [Related]
9. Rapid detection of mutations associated with resistance to erythromycin in Campylobacter jejuni/coli by PCR and line probe assay.
Niwa H; Chuma T; Okamoto K; Itoh K
Int J Antimicrob Agents; 2001 Oct; 18(4):359-64. PubMed ID: 11691569
[TBL] [Abstract][Full Text] [Related]
10. Study of the molecular mechanisms involved in high-level macrolide resistance of Spanish Campylobacter jejuni and Campylobacter coli strains.
Pérez-Boto D; López-Portolés JA; Simón C; Valdezate S; Echeita MA
J Antimicrob Chemother; 2010 Oct; 65(10):2083-8. PubMed ID: 20647243
[TBL] [Abstract][Full Text] [Related]
11. Formation of the Resistance of Campylobacter jejuni to Macrolide Antibiotics.
Efimochkina NR; Stetsenko VV; Sheveleva SA
Bull Exp Biol Med; 2020 Jul; 169(3):351-356. PubMed ID: 32748135
[TBL] [Abstract][Full Text] [Related]
12. Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli.
Cagliero C; Mouline C; Cloeckaert A; Payot S
Antimicrob Agents Chemother; 2006 Nov; 50(11):3893-6. PubMed ID: 16940070
[TBL] [Abstract][Full Text] [Related]
13. Quinolone and Macrolide-Resistant
Abbasi E; van Belkum A; Ghaznavi-Rad E
Microb Drug Resist; 2019 Sep; 25(7):1080-1086. PubMed ID: 31021299
[No Abstract] [Full Text] [Related]
14. Molecular Basis of Macrolide Resistance in
Wei B; Kang M
Biomed Res Int; 2018; 2018():4526576. PubMed ID: 30069469
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adhesion, invasion, motility, and toxin production of Campylobacter strains and their resistant mutants.
Zeitouni S; Guyard-Nicodème M; Kempf I
Microb Drug Resist; 2013 Apr; 19(2):130-7. PubMed ID: 23095083
[TBL] [Abstract][Full Text] [Related]
16. A Highly Macrolide-Resistant Campylobacter jejuni Strain with Rare A2074T Mutations in 23S rRNA Genes.
Ohno H; Wachino J; Saito R; Jin W; Yamada K; Kimura K; Arakawa Y
Antimicrob Agents Chemother; 2016 Apr; 60(4):2580-1. PubMed ID: 26810658
[No Abstract] [Full Text] [Related]
17. MAMA-PCR assay for the detection of point mutations associated with high-level erythromycin resistance in Campylobacter jejuni and Campylobacter coli strains.
Alonso R; Mateo E; Churruca E; Martinez I; Girbau C; Fernández-Astorga A
J Microbiol Methods; 2005 Oct; 63(1):99-103. PubMed ID: 15927294
[TBL] [Abstract][Full Text] [Related]
18. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter.
Corcoran D; Quinn T; Cotter L; Fanning S
Int J Antimicrob Agents; 2006 Jan; 27(1):40-5. PubMed ID: 16318913
[TBL] [Abstract][Full Text] [Related]
19. Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens.
Lin J; Yan M; Sahin O; Pereira S; Chang YJ; Zhang Q
Antimicrob Agents Chemother; 2007 May; 51(5):1678-86. PubMed ID: 17353243
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey.
Kayman T; Abay S; Aydin F; Şahin O
J Med Microbiol; 2019 Feb; 68(2):136-142. PubMed ID: 30540246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
